top of page

California Gov. Gavin Newsom says California will develop its own low-cost insulin


Photo Credit: Gage Skidmore


In an announcement made on Thursday, California Governor Gavin Newsom said the state will develop its own "low-cost" insulin, an essential hormone that many people use for diabetes treatment.



“Many Americans experience out-of-pocket costs anywhere from $300 to $500 per month for this life-saving drug,” he said. “California is now taking matters into its own hands. The budget I just signed sets aside $100 million so we can contract and make our own insulin at a cheaper price, close to at cost, and make it available to all.”


In a video shared on Twitter, he said that “people should not go into debt to receive life-saving medication.”

The state budget for this year is $308 billion, which was signed by Newsom last week. The budget will dedicate $50 million to developing low-cost insulin products, and another $50 million "will be used to build an insulin manufacturing facility in California" that will "create new, high-paying jobs and strengthen the diabetes medication supply chain," he said.



8 July 2022


 
 
Capitol Times magazine Issue 5
Capitol times magazine 9
Capitol times magazine 10

Contact us

Letter to Editor-In-Chief
Editor@capitoltimesmedia.com

For Advertising in
Capitol Times Magazine:

ads@capitoltimesmedia.com

FOLLOW US

  • X
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

Join our mailing list

Disclaimer:

Capitol Times Magazine Online and Print on-Demand magazine. The views and opinions expressed in the articles or Interviews published in this magazine are solely those of the respective authors and do not necessarily reflect the official policy or position of the Capitol Times magazine or Capitol Times Media , its editors, or its staff. The authors are solely responsible for the content of their articles. The magazine strives to provide a platform for diverse voices and opinions, and we value the principle of free expression. The magazine assumes no responsibility or liability for any errors or omissions in the content of the articles. In no event shall the Capitol Times magazine or Capitol Times Media be liable for any special, direct, indirect, or incidental damages. Furthermore, the inclusion of advertisements or sponsored content in Capitol Times magazine does not constitute an endorsement or guarantee of the products, services, or views promoted by the advertisers. Readers are encouraged to conduct their own research and exercise caution when making decisions based on advertisements or sponsored content featured in this publication.

Thank you for reading and engaging with our publication. Your feedback is valuable to us as we continue to provide a platform for thought-provoking content and diverse perspectives.

 

Disclaimer:
Capitol Times Media is a privately owned and independently operated media that publish Capitol Times Magazine. It is not affiliated with, endorsed by, or connected to the United States government, the U.S. Capitol, Congress, or any federal, state, or local government agency. 
Content published by Capitol Times Magazine includes both editorial content and sponsored or paid content.


© 2026 by Capitol Times Media LLC - Privacy Policy

bottom of page